Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pudendal Nerve Block for CRBD in TURP/TURBT
NCT05022160Phase 1Unknown
- Sponsor
- Combined Military Hospital
- Start
- Aug 2021
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ropivacaine in cystitis (2 arms), sponsored by Combined Military Hospital. Primary endpoint: Frequency of Catheter Related Bladder Discomfort at 24 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT05022160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022160.